Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

A roadmap to integrate astrocytes into Systems Neuroscience.

Kastanenka KV, Moreno-Bote R, De Pittà M, Perea G, Eraso-Pichot A, Masgrau R, Poskanzer KE, Galea E.

Glia. 2019 May 6. doi: 10.1002/glia.23632. [Epub ahead of print] Review.

PMID:
31058383
2.

GSEA of mouse and human mitochondriomes reveals fatty acid oxidation in astrocytes.

Eraso-Pichot A, Brasó-Vives M, Golbano A, Menacho C, Claro E, Galea E, Masgrau R.

Glia. 2018 Aug;66(8):1724-1735. doi: 10.1002/glia.23330. Epub 2018 Mar 25.

PMID:
29575211
3.

Author Correction: Neurons and neuronal activity control gene expression in astrocytes to regulate their development and metabolism.

Hasel P, Dando O, Jiwaji Z, Baxter P, Todd AC, Heron S, Márkus NM, McQueen J, Hampton DW, Torvell M, Tiwari SS, McKay S, Eraso-Pichot A, Zorzano A, Masgrau R, Galea E, Chandran S, Wyllie DJA, Simpson TI, Hardingham GE.

Nat Commun. 2018 Feb 6;9:16176. doi: 10.1038/ncomms16176.

4.

Neuroprotective Drug for Nerve Trauma Revealed Using Artificial Intelligence.

Romeo-Guitart D, Forés J, Herrando-Grabulosa M, Valls R, Leiva-Rodríguez T, Galea E, González-Pérez F, Navarro X, Petegnief V, Bosch A, Coma M, Mas JM, Casas C.

Sci Rep. 2018 Jan 30;8(1):1879. doi: 10.1038/s41598-018-19767-3.

5.

Phagocytic clearance of presynaptic dystrophies by reactive astrocytes in Alzheimer's disease.

Gomez-Arboledas A, Davila JC, Sanchez-Mejias E, Navarro V, Nuñez-Diaz C, Sanchez-Varo R, Sanchez-Mico MV, Trujillo-Estrada L, Fernandez-Valenzuela JJ, Vizuete M, Comella JX, Galea E, Vitorica J, Gutierrez A.

Glia. 2018 Mar;66(3):637-653. doi: 10.1002/glia.23270. Epub 2017 Nov 27.

6.

CREB Regulates Distinct Adaptive Transcriptional Programs in Astrocytes and Neurons.

Pardo L, Valor LM, Eraso-Pichot A, Barco A, Golbano A, Hardingham GE, Masgrau R, Galea E.

Sci Rep. 2017 Jul 25;7(1):6390. doi: 10.1038/s41598-017-06231-x.

7.

Should We Stop Saying 'Glia' and 'Neuroinflammation'?

Masgrau R, Guaza C, Ransohoff RM, Galea E.

Trends Mol Med. 2017 Jun;23(6):486-500. doi: 10.1016/j.molmed.2017.04.005. Epub 2017 May 9. Review.

PMID:
28499701
8.

Neurons and neuronal activity control gene expression in astrocytes to regulate their development and metabolism.

Hasel P, Dando O, Jiwaji Z, Baxter P, Todd AC, Heron S, Márkus NM, McQueen J, Hampton DW, Torvell M, Tiwari SS, McKay S, Eraso-Pichot A, Zorzano A, Masgrau R, Galea E, Chandran S, Wyllie DJA, Simpson TI, Hardingham GE.

Nat Commun. 2017 May 2;8:15132. doi: 10.1038/ncomms15132. Erratum in: Nat Commun. 2018 Feb 06;9:16176.

9.

Tauroursodeoxycholic bile acid arrests axonal degeneration by inhibiting the unfolded protein response in X-linked adrenoleukodystrophy.

Launay N, Ruiz M, Grau L, Ortega FJ, Ilieva EV, Martínez JJ, Galea E, Ferrer I, Knecht E, Pujol A, Fourcade S.

Acta Neuropathol. 2017 Feb;133(2):283-301. doi: 10.1007/s00401-016-1655-9. Epub 2016 Dec 21.

10.

CREB decreases astrocytic excitability by modifying subcellular calcium fluxes via the sigma-1 receptor.

Eraso-Pichot A, Larramona-Arcas R, Vicario-Orri E, Villalonga R, Pardo L, Galea E, Masgrau R.

Cell Mol Life Sci. 2017 Mar;74(5):937-950. doi: 10.1007/s00018-016-2397-5. Epub 2016 Oct 19.

PMID:
27761593
11.

Targeted activation of CREB in reactive astrocytes is neuroprotective in focal acute cortical injury.

Pardo L, Schlüter A, Valor LM, Barco A, Giralt M, Golbano A, Hidalgo J, Jia P, Zhao Z, Jové M, Portero-Otin M, Ruiz M, Giménez-Llort L, Masgrau R, Pujol A, Galea E.

Glia. 2016 May;64(5):853-74. doi: 10.1002/glia.22969. Epub 2016 Feb 16.

PMID:
26880229
12.

Topological analyses in APP/PS1 mice reveal that astrocytes do not migrate to amyloid-β plaques.

Galea E, Morrison W, Hudry E, Arbel-Ornath M, Bacskai BJ, Gómez-Isla T, Stanley HE, Hyman BT.

Proc Natl Acad Sci U S A. 2015 Dec 22;112(51):15556-61. doi: 10.1073/pnas.1516779112. Epub 2015 Dec 7.

13.

Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy.

Morató L, Galino J, Ruiz M, Calingasan NY, Starkov AA, Dumont M, Naudí A, Martínez JJ, Aubourg P, Portero-Otín M, Pamplona R, Galea E, Beal MF, Ferrer I, Fourcade S, Pujol A.

Brain. 2013 Aug;136(Pt 8):2432-43. doi: 10.1093/brain/awt143. Epub 2013 Jun 22.

14.

Cyclophilin D as a potential target for antioxidants in neurodegeneration: the X-ALD case.

López-Erauskin J, Ferrer I, Galea E, Pujol A.

Biol Chem. 2013 May;394(5):621-9. doi: 10.1515/hsz-2012-0323. Review.

PMID:
23492556
15.

ATP and noradrenaline activate CREB in astrocytes via noncanonical Ca(2+) and cyclic AMP independent pathways.

Carriba P, Pardo L, Parra-Damas A, Lichtenstein MP, Saura CA, Pujol A, Masgrau R, Galea E.

Glia. 2012 Sep;60(9):1330-44. doi: 10.1002/glia.22352. Epub 2012 May 16.

PMID:
22593004
16.

Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: a paradigm for multifactorial neurodegenerative diseases?

Galea E, Launay N, Portero-Otin M, Ruiz M, Pamplona R, Aubourg P, Ferrer I, Pujol A.

Biochim Biophys Acta. 2012 Sep;1822(9):1475-88. doi: 10.1016/j.bbadis.2012.02.005. Epub 2012 Feb 12. Review.

17.

JNK/ERK/FAK mediate promigratory actions of basic fibroblast growth factor in astrocytes via CCL2 and COX2.

Lichtenstein MP, Madrigal JL, Pujol A, Galea E.

Neurosignals. 2012;20(2):86-102. doi: 10.1159/000330805. Epub 2011 Dec 22.

18.

Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy.

Schlüter A, Espinosa L, Fourcade S, Galino J, López E, Ilieva E, Morató L, Asheuer M, Cook T, McLaren A, Reid J, Kelly F, Bates S, Aubourg P, Galea E, Pujol A.

Hum Mol Genet. 2012 Mar 1;21(5):1062-77. doi: 10.1093/hmg/ddr536. Epub 2011 Nov 17.

19.

Staging anti-inflammatory therapy in Alzheimer's disease.

Lichtenstein MP, Carriba P, Masgrau R, Pujol A, Galea E.

Front Aging Neurosci. 2010 Oct 25;2:142. doi: 10.3389/fnagi.2010.00142. eCollection 2010.

20.

Secretase-independent and RhoGTPase/PAK/ERK-dependent regulation of cytoskeleton dynamics in astrocytes by NSAIDs and derivatives.

Lichtenstein MP, Carriba P, Baltrons MA, Wojciak-Stothard B, Peterson JR, García A, Galea E.

J Alzheimers Dis. 2010;22(4):1135-55. doi: 10.3233/JAD-2010-101332.

PMID:
20930267
21.

Altered distribution of RhoA in Alzheimer's disease and AbetaPP overexpressing mice.

Huesa G, Baltrons MA, Gómez-Ramos P, Morán A, García A, Hidalgo J, Francés S, Santpere G, Ferrer I, Galea E.

J Alzheimers Dis. 2010;19(1):37-56. doi: 10.3233/JAD-2010-1203.

PMID:
20061625
22.

Increasing CNS noradrenaline reduces EAE severity.

Simonini MV, Polak PE, Sharp A, McGuire S, Galea E, Feinstein DL.

J Neuroimmune Pharmacol. 2010 Jun;5(2):252-9. doi: 10.1007/s11481-009-9182-2. Epub 2009 Dec 4.

PMID:
19957206
23.

Molecular targets of non-steroidal anti-inflammatory drugs in neurodegenerative diseases.

Lleo A, Galea E, Sastre M.

Cell Mol Life Sci. 2007 Jun;64(11):1403-18. Review.

PMID:
17447008
24.

Degeneration of noradrenergic fibres from the locus coeruleus causes tight-junction disorganisation in the rat brain.

Kalinin S, Feinstein DL, Xu HL, Huesa G, Pelligrino DA, Galea E.

Eur J Neurosci. 2006 Dec;24(12):3393-400.

PMID:
17229089
25.

Non-chromosome 11-p syndromes in Wilms tumor patients: Clinical and cytogenetic report of two Down syndrome cases and one Turner syndrome case.

Spreafico F, Terenziani M, Lualdi E, Scarfone P, Collini P, Fossati-Bellani F, Galea E, De Vecchi G, Sardella M, Sozzi G, Radice P, Perotti D.

Am J Med Genet A. 2007 Jan 1;143A(1):85-8. No abstract available.

PMID:
17163536
26.

Pioglitazone does not increase cerebral glucose utilisation in a murine model of Alzheimer's disease and decreases it in wild-type mice.

Galea E, Feinstein DL, Lacombe P.

Diabetologia. 2006 Sep;49(9):2153-61. Epub 2006 Jul 8.

PMID:
16830140
27.

Effect of anti-inflammatory agents on transforming growth factor beta over-expressing mouse brains: a model revised.

Lacombe P, Mathews PM, Schmidt SD, Breidert T, Heneka MT, Landreth GE, Feinstein DL, Galea E.

J Neuroinflammation. 2004 Jul 2;1(1):11.

28.

Intrinsic regulation of brain inflammatory responses.

Galea E, Heneka MT, Dello Russo C, Feinstein DL.

Cell Mol Neurobiol. 2003 Oct;23(4-5):625-35. Review.

PMID:
14514020
29.

Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro.

Tassone P, Tagliaferri P, Viscomi C, Palmieri C, Caraglia M, D'Alessandro A, Galea E, Goel A, Abbruzzese A, Boland CR, Venuta S.

Br J Cancer. 2003 Jun 16;88(12):1971-8.

30.

Peroxisome proliferator-activated receptor gamma thiazolidinedione agonists increase glucose metabolism in astrocytes.

Dello Russo C, Gavrilyuk V, Weinberg G, Almeida A, Bolanos JP, Palmer J, Pelligrino D, Galea E, Feinstein DL.

J Biol Chem. 2003 Feb 21;278(8):5828-36. Epub 2002 Dec 16.

31.
32.

Noradrenergic regulation of inflammatory gene expression in brain.

Feinstein DL, Heneka MT, Gavrilyuk V, Dello Russo C, Weinberg G, Galea E.

Neurochem Int. 2002 Nov;41(5):357-65. Review.

PMID:
12176079
33.

Differential expression of UN1, early thymocyte-associated sialoglycoprotein, in breast normal tissue, benign disease and carcinomas.

Tassone P, Bonelli P, Tuccillo F, Bond HM, D'Armiento FP, Galea E, Palmieri C, Tagliaferri P, Natali PG, Venuta S.

Anticancer Res. 2002 Jul-Aug;22(4):2333-40.

PMID:
12174923
34.

Estrogen inhibits NF kappa B-dependent inflammation in brain endothelium without interfering with I kappa B degradation.

Galea E, Santizo R, Feinstein DL, Adamsom P, Greenwood J, Koenig HM, Pelligrino DA.

Neuroreport. 2002 Aug 7;13(11):1469-72.

PMID:
12167775
35.

Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis.

Feinstein DL, Galea E, Gavrilyuk V, Brosnan CF, Whitacre CC, Dumitrescu-Ozimek L, Landreth GE, Pershadsingh HA, Weinberg G, Heneka MT.

Ann Neurol. 2002 Jun;51(6):694-702.

PMID:
12112074
36.

Oxaliplatin (L-OHP) treatment of human myeloma cells induces in vitro growth inhibition and apoptotic cell death.

Tassone P, Tagliaferri P, Galea E, Palmieri C, Bonelli P, Martelli ML, Tuccillo F, Turco MC, Venuta S.

Eur J Cancer. 2002 May;38(8):1141-7.

PMID:
12008204
37.

Noradrenergic depletion potentiates beta -amyloid-induced cortical inflammation: implications for Alzheimer's disease.

Heneka MT, Galea E, Gavriluyk V, Dumitrescu-Ozimek L, Daeschner J, O'Banion MK, Weinberg G, Klockgether T, Feinstein DL.

J Neurosci. 2002 Apr 1;22(7):2434-42.

38.
39.

The key role of caveolin-1 in estrogen-mediated regulation of endothelial nitric oxide synthase function in cerebral arterioles in vivo.

Xu HL, Galea E, Santizo RA, Baughman VL, Pelligrino DA.

J Cereb Blood Flow Metab. 2001 Aug;21(8):907-13.

PMID:
11487725
40.

Estrogen and cerebrovascular physiology and pathophysiology.

Pelligrino DA, Galea E.

Jpn J Pharmacol. 2001 Jun;86(2):137-58. Review.

41.

Local anesthetics potentiate nitric oxide synthase type 2 expression in rat glial cells.

Feinstein DL, Murphy P, Sharp A, Galea E, Gavrilyuk V, Weinberg G.

J Neurosurg Anesthesiol. 2001 Apr;13(2):99-105.

PMID:
11294465
42.

Synergistic induction of growth arrest and apoptosis of human myeloma cells by the IL-6 super-antagonist Sant7 and Dexamethasone.

Tassone P, Forciniti S, Galea E, Savino R, Turco MC, Iacopino P, Tagliaferri P, Morrone G, Ciliberto G, Venuta S.

Cell Death Differ. 2000 Mar;7(3):327-8. No abstract available.

43.

Growth inhibition and synergistic induction of apoptosis by zoledronate and dexamethasone in human myeloma cell lines.

Tassone P, Forciniti S, Galea E, Morrone G, Turco MC, Martinelli V, Tagliaferri P, Venuta S.

Leukemia. 2000 May;14(5):841-4.

PMID:
10803515
44.

Cyclic adenosine monophosphate regulates the expression of the intercellular adhesion molecule and the inducible nitric oxide synthase in brain endothelial cells.

Balyasnikova IV, Pelligrino DA, Greenwood J, Adamson P, Dragon S, Raza H, Galea E.

J Cereb Blood Flow Metab. 2000 Apr;20(4):688-99.

PMID:
10779013
45.
46.

Regulation of the expression of the inflammatory nitric oxide synthase (NOS2) by cyclic AMP.

Galea E, Feinstein DL.

FASEB J. 1999 Dec;13(15):2125-37. Review.

PMID:
10593859
47.

Stimulation of cerebellar fastigial nucleus inhibits interleukin-1beta-induced cerebrovascular inflammation.

Galea E, Glickstein SB, Feinstein DL, Golanov EV, Reis DJ.

Am J Physiol. 1998 Dec;275(6):H2053-63. doi: 10.1152/ajpheart.1998.275.6.H2053.

PMID:
9843804
48.

Cerebellar stimulation reduces inducible nitric oxide synthase expression and protects brain from ischemia.

Galea E, Golanov EV, Feinstein DL, Kobylarz KA, Glickstein SB, Reis DJ.

Am J Physiol. 1998 Jun;274(6):H2035-45. doi: 10.1152/ajpheart.1998.274.6.H2035.

PMID:
9841530
49.

Central neurogenic neuroprotection: central neural systems that protect the brain from hypoxia and ischemia.

Reis DJ, Golanov EV, Galea E, Feinstein DL.

Ann N Y Acad Sci. 1997 Dec 19;835:168-86. Review.

PMID:
9616772
50.

Metabolism of agmatine in macrophages: modulation by lipopolysaccharide and inhibitory cytokines.

Sastre M, Galea E, Feinstein D, Reis DJ, Regunathan S.

Biochem J. 1998 Mar 15;330 ( Pt 3):1405-9.

Supplemental Content

Support Center